Terry A Jacobson MD

Affiliations:

No affiliations have been saved.

External Links (e.g. Departmental web site):

No external links have been saved.

Degrees Held:

No degrees have been saved.

Research Interests:

No research interests have been saved.

Biography/Description of Research:

No biography information has been saved.

Works 1-10 of 21

  1. 1
  2. 2
  3. 3

Article

Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT

by Brian Olshansky; Deepak L Bhatt; Michael Miller; Ph Gabriel Steg; Eliot A Brinton; Terry Jacobson; Steven B Ketchum; Ralph T Doyle Jr; Rebecca A Juliano; Lixia Jiao; Peter R Kowey; James A Reiffel; Jean-Claude Tardif; Christie M Ballantyne; Mina K Chung

2023

Article

The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint clinical perspective from the National Lipid Association and the American Society for Preventive Cardiology

by Salim S Virani; Karen Aspry; Dave L Dixon; Keith C Ferdinand; Paul A Heidenreich; Elizabeth J Jackson; Terry Jacobson; Janice L McAlister; David R Neff; Martha Gulati; Christie M Ballantyne

2023

Article

REDUCE-IT INTERIM: accumulation of data across prespecified interim analyses to final results

by Brian Olshansky; Deepak L Bhatt; Michael Miller; Gabriel Ph Steg; Eliot A Brinton; Terry Jacobson; Steven B Ketchum; Ralph T Doyle Jr; Rebecca A Juliano; Lixia Jiao; Craig Granowitz; Jean-Claude Tardif; Cyrus Mehta; Rajat Mukherjee; Christie M Ballantyne; Mina K Chung

2021

Article

Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment

by William Weintraub; Deepak L. Bhatt; Zugui Zhang; Sarahfaye Dolman; William E. Boden; Adam P. Bress; Jordan B. King; Brandon K. Bellows; Gabriel S. Tajeu; Catherine G. Derington; Jonathan Johnson; Katherine Andrade; P. Gabriel Steg; Michael Miller; Eliot A. Brinton; Terry Jacobson; Jean-Claude Tardif; Christie M. Ballantyne; Paul Kolm

2022

Article

REDUCE-IT USA Results From the 3146 Patients Randomized in the United States

by Deepak L. Bhatt; Michael Miller; Eliot A. Brinton; Terry Jacobson; Ph. Gabriel Steg; Steven B. Ketchum; Ralph T. Doyle; Rebecca A. Juliano; Lixia Jiao; Craig Granowitz; Jean-Claude Tardif; Brian Olshansky; Mina K. Chung; C. Michael Gibson; Robert P. Giugliano; Matthew J. Budoff; Christie M. Ballantyne

2020

Article

Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL

by Arjun Majithia; Deepak L Bhatt; Allon N Friedman; Michael Miller; Gabriel Ph Steg; Eliot A Brinton; Terry Jacobson; Steven B Ketchum; Rbecca A Juliano; Lixia Jiao; Ralph T Doyle; Craig Granowitz; Matthew Budoff; Preston R Mason; Jean-Claude Tardif; William E Boden; Christie M Ballantyne

2021

Article

Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in Patients With Heart Failure in REDUCE‐IT

by Senthil Selvaraj; Deepak L. Bhatt; Ph. Gabriel Steg; Michael Miller; Eliot Brinton; Terry Jacobson; Rebecca A. Juliano; Lixia Jiao; Jean-Claude Tardif; Christie M. Ballantyne

2022

Article

Reduction in Revascularization With Icosapent Ethyl Insights From REDUCE-IT Revascularization Analyses

by Benjamin E. Peterson; Deepak L. Bhatt; Ph. Gabriel Steg; Michael Miller; Eliot A. Brinton; Terry Jacobson; Steven B. Ketchum; Rebecca A. Juliano; Lixia Jiao; Ralph T. Doyle; Craig Granowitz; C. Michael Gibson; Duane Pinto; Robert P. Giugliano; Matthew J. Budoff; Jean-Claude Tardif; Subodh Verma; Christie M. Ballantyne

2021